Hepatitis B Trial, Recruiting NCT06550622 Sponsor: Huashan Hospital Condition: Hepatitis B
Back to Hepatitis B

Hepatitis B Trial, Recruiting

NCT06550622
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your blood test shows that a specific hepatitis B protein (HBsAg) is no longer detectable, and another hepatitis B marker (HBeAg) is also not detectable
  • You have blood samples that were stored both at the start of a previous treatment and at 48 weeks after that treatment ended
  • You are willing to attend regular check-up visits for 1 year

Who may not be able to join:

  • You have been diagnosed with liver scarring (cirrhosis) related to hepatitis B, whether mild or severe — including if you have had serious complications such as fluid build-up in the abdomen, confusion caused by liver problems, or bleeding from swollen veins in the stomach or food pipe
  • You have another liver condition alongside hepatitis B, such as hepatitis A, C, D, E, or HIV, alcoholic liver disease, fatty liver disease, autoimmune liver disease, or any other ongoing liver condition
  • You have liver cancer, or your blood test or scan results suggest there may be a possibility of liver cancer
  • You currently have, or have had, another type of cancer that has not been fully cured
  • You have a serious or poorly controlled medical condition (confirm with trial site)
  • You are currently taking part in another clinical trial
  • The trial doctor decides for any reason that this trial is not right for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13524212580

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Huashan Hospital
Registry
ClinicalTrials.gov
Start date
10 August 2024
Est. completion
10 August 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

HBsAg reversion rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov